Login Register
icon_bulk_orderBulk order Acrobiosystems for ChineseChinese
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
SARS-CoV-2  Omicron |Delta |Claudin 18.2 | CD20 | CD3 | GPCRs | IL-2R
0
There is no goods in the shopping cart !
My Cart
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > COVID-19 R&D
COVID-19 R&D
News
Exhibitions
Promotion
ACROBiosystems races to kick off lab studies of Omicron
2021/12/07     Read: 236
ACRO Speed: High Quality Omicron Antigens Developed Within 10 days
2021/12/06     Read: 858
According to the mutations: Why is Omicron causing such concern?
On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron. Due to its highly divergent, researchers are now highly focused on the influence of rare mutations present in Omicron on current vaccines and therapeutic antibodies.
2021/11/30     Read: 3010
SARS-CoV-2 variants, immune escape and multivalent vaccine candidates: What ACRO offers to solve the biggest problem
The emergence and persistence of SARS-CoV-2 variants pose a continuing threat to global health. Since the first potent spike mutation, D614G, was identified in February 2020, a significant number of spike mutations that alter virus fitness were successively characterized. To better track and report
2021/11/05     Read: 5706
Where do we go from here: A reflection of COVID-19
This article is a reflection of COVID-19, following some possible solutions for related research, vaccine and diagnostics development.
2021/09/10     Read: 6734
Binding and neutralizing antibodies correlated with COVID-19 risk and vaccine efficacy
2021/08/13     Read: 3195
What You Should Know About the Lambda Variant
2021/08/12     Read: 7701
Accelerated Progress: Spike Protein Mutations on B.1.617 Identified and Studied
After the sharp rise in COVID-19 cases and deaths in India over recent weeks, at least 20 countries have imposed travel bans and restrictions to and from India. The world again stands at a crossroad of the viral evolution.
2021/05/11     Read: 6456
ACROBiosystems makes donations to BEI Resources, accelerating the process of attacking SARS-CoV-2 variants globally
Multiple SARS-CoV-2 variants are emerging and circulating globally; the battle against COVID-19 pandemic is still challenging. Recently, ACROBiosystems donated SARS-CoV-2 mutant proteins to BEI Resources, a NIAID funded bioresource program, joining in the collective effort in attacking SARS-CoV-2 va
2021/05/10     Read: 2635
The B.1.617 is Likely Behind the Recent Surge of COVID-19 Cases in India
How dangerous is the Indian ‘double mutant’ of SARS-CoV-2?
2021/04/26     Read: 7142
More

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
中文网站|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap